UK's GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion
09/06/2026 07:01
UK's GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion June 9 (Reuters) - British drugmaker GSK GSK.L on Tuesday agreed to acquire U.S.-listed cancer drug developer Nuvalent NUVL.O for $10.6 billion.
(Reporting by DhanushVignesh Babu and Yadarisa Shabong in Bengaluru)